Edition:
India

Sinopharm Group Co Ltd (1099.HK)

1099.HK on Hong Kong Stock

19.30HKD
1 Dec 2020
Change (% chg)

HK$0.14 (+0.73%)
Prev Close
HK$19.16
Open
HK$19.38
Day's High
HK$19.64
Day's Low
HK$19.16
Volume
7,893,820
Avg. Vol
9,942,795
52-wk High
HK$29.55
52-wk Low
HK$14.70

Latest Key Developments (Source: Significant Developments)

Blackrock Inc's Long Position In Sinopharm Group Falls To 5.97% - HKEX Filing
Monday, 16 Nov 2020 

Nov 16 (Reuters) - Hong Kong stock exchange filing: :BLACKROCK INC SOLD 773,200 H-SHARES IN SINOPHARM GROUP <<<1099.HK>>> AT AVG PRICE OF HK$19.1886 ($2.47) PER SHARE ON NOV 12 - HKEX FILING.BLACKROCK INC'S LONG POSITION IN SINOPHARM GROUP DECREASES TO 5.97% FROM 6.03% - HKEX FILING.  Full Article

Sinopharm Group Posts 9-Month Net Profit Attributable RMB4.96 Billion
Friday, 23 Oct 2020 

Oct 23 (Reuters) - Sinopharm Group Co Ltd <1099.HK>::9-MONTH NET PROFIT ATTRIBUTABLE RMB4.96 BILLION VERSUS RMB4.60 BILLION.9-MONTH TOTAL OPERATING REVENUE RMB327.61 BILLION VERSUS RMB312.69 BILLION.  Full Article

Sinopharm Group Resolves To Elect Li Zhiming As Chairman
Friday, 18 Sep 2020 

Sept 18 (Reuters) - Sinopharm Group Co Ltd <1099.HK>::RESOLVED TO ELECT LI ZHIMING AS CHAIRMAN.RESOLVED TO ELECT CHEN QIYU AS VICE CHAIRMAN.  Full Article

Sinopharm Group Says Will Form JV Co With CNBG, Guangdong Medi-World & Others
Monday, 6 Jul 2020 

July 6 (Reuters) - Sinopharm Group Co Ltd <1099.HK>::ENTERED JV AGREEMENT WITH CHINA NATIONAL PHARMACEUTICAL GROUP.CO TO CONTRIBUTE RMB60 MILLION, REPRESENTING 60% OF TOTAL CAPITAL CONTRIBUTIONS OF JV CO.TO FORM JV CO WITH CNBG GUANGDONG MEDI-WORLD, SHYNDEC PHARMACEUTICAL & CHINA STATE INSTITUTE OF PHARMACEUTICAL INDUSTRY.REGISTERED CAPITAL OF JV CO IS RMB100 MILLION.JVCO TO FORM AN INTERNET PLATFORM CO UNDER NATIONAL MEDICAL & PHARMACEUTICAL EMERGENCY PROTECTION SYSTEM.  Full Article

Sinopharm Group Posts Qtrly Total Operating Revenue RMB94.40 Bln
Monday, 27 Apr 2020 

April 27 (Reuters) - Sinopharm Group Co Ltd <1099.HK>::QTRLY TOTAL OPERATING REVENUE RMB94.40 BILLION VERSUS RMB95.18 BILLION.QTRLY NET PROFIT ATTRIBUTABLE RMB812 MILLION VERSUS RMB1.14 BILLION.  Full Article

Sinopharm Group Co Announces Placing Of H Shares
Friday, 17 Jan 2020 

Jan 17 (Reuters) - Sinopharm Group Co Ltd <1099.HK>::CO TO PLACE 149 MILLION NEW H SHARES AT PLACING PRICE OF HK$27.30 PER H SHARE.MAXIMUM AMOUNT OF NET PROCEEDS OF PLACING WILL BE ABOUT HK$4,021.5 MILLION.  Full Article

Sinopharm Group 9-Month Net Profit Attributable RMB 4.60 Billion
Monday, 28 Oct 2019 

Oct 28 (Reuters) - Sinopharm Group Co Ltd <1099.HK>::9-MONTH NET PROFIT ATTRIBUTABLE RMB 4.60 BILLION VERSUS RMB 4.12 BILLION.9-MONTH TOTAL OPERATING REVENUE RMB 312.69 BILLION VERSUS RMB 250.82 BILLION.  Full Article

Sinopharm Group Posts HY Profit Attributable Of RMB2.98 Bln
Monday, 26 Aug 2019 

Aug 26 (Reuters) - Sinopharm Group Co Ltd <1099.HK>::HY PROFIT ATTRIBUTABLE RMB2.98 BILLION VERSUS RMB2.80 BILLION.HY REVENUE $201.67 BILLION VERSUS RMB163.47 BILLION.  Full Article

Peru secures 23.1 million future coronavirus vaccine doses from Pfizer, COVAX

SANTIAGO, Nov 27 Peru has secured enough coronavirus vaccine to give nearly three-quarters of its population at least one dose when the immunization is available, a hopeful development for a nation with one of the highest COVID-19 death rates in the world.